About ajuurinen@xtalks.com

  • Member Since: July 15, 2016

Description

Ads / Latest items listed

Medidata_Logo_Color_CMYK-01 x200
Medidata_Logo_Color_CMYK-01 x200

This presentation will discuss the paradigm shift in payment tracking from excel or home-grown systems to more commercial, turn-key technology. Sponsors have hi...

xtalks logo
xtalks logo

Ensuring that psychiatry clinical trial data accurately captures a compound’s safety and efficacy potential requires an approach that accounts for challenges in...

xtalks logo
xtalks logo

This webinar will give an overview of endpoint assessment as it relates to RECIST, irRC, and clinical benefit in the setting of cancer immunotherapy. Recommenda...

xtalks logo
xtalks logo

When and how should a biopharma start-up consider establishing their own Medical Safety group? The opportunities and challenges differ greatly between an emergi...

xtalks logo
xtalks logo

The maintenance of cold chain product integrity across the entire supply chain demands rigorous processes and cold chain expertise of the highest calibre – from...

xtalks logo
xtalks logo

This webinar reviews the history of patient advocacy groups in advancing clinical research and examines the evolution of their role in light of recent and pendi...

xtalks logo
xtalks logo

In this webinar, we will focus on specific pharmaceutical case study examples that illustrate how to drive innovation through an enhanced data strategy. Our exp...

xtalks logo
xtalks logo

This session details best practices for onboarding RBM that have been gained through implementation involving smaller and larger BioPharma sponsors and CROs. ...

xtalks logo
xtalks logo

As a type of Clinical Outcome Assessment (COA), Performance Outcome assessments (PerfOs) specifically refer to task(s) performed by a patient according to instr...

xtalks logo
xtalks logo

Non-alcoholic fatty liver disease (NAFLD) / Non-alcoholic steatohepatitis (NASH) has been pronounced the next major health epidemic. This declaration is, in par...

xtalks logo
xtalks logo

This presentation will discuss the paradigm shift in payment tracking from excel or home-grown systems to more commercial, turn-key technology. Sponsors have hi...

xtalks logo
xtalks logo

Launching an orphan drug product onto the European market can present a real challenge if the company is not familiar with country specific requirements. With i...

xtalks logo
xtalks logo

The faster you start and execute a clinical trial, the faster a new product is released to market and the longer that drug is commercially-available under paten...

xtalks logo
xtalks logo

This webinar introduces participants to Pathogen Environmental Monitoring Programs that assure their facilities are safe for food production. The discussion ...

xtalks logo
xtalks logo

A wide and growing range of imaging modalities and analysis methods are available for use in oncology and hematology clinical trials. This reflects the understa...

xtalks_logo
xtalks_logo

Interest in the microbiome and its role in health and disease is a rapidly growing research focus for academic institutions, biotech and pharmaceutical companie...